Related Experiment Video

Updated: Jul 8, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

The therapeutic potential of stem cells in heart disease

B E Strauer1, M Brehm, C M Schannwell

  • 1Department of Cardiology, Pneumology and Vascular Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. strauer@med.uni-duesseldorf.de

Cell Proliferation
|January 10, 2008
PubMed

Insights

Intracoronary stem cell therapy using autologous bone marrow cells offers a safe and effective method for regenerating heart muscle damaged by coronary heart disease and heart failure. This regenerative approach shows promise even for old heart damage, improving cardiac function.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Coronary heart disease and chronic heart failure are prevalent conditions with increasing incidence.
  • Current therapies can delay but not prevent or reverse ventricular remodeling, impacting quality of life and cardiac function.
  • There is a need for effective regenerative strategies to repair damaged heart muscle.

Purpose of the Study:

  • To evaluate the safety and efficacy of intracoronary stem cell therapy for regenerating compromised heart muscle.
  • To assess the potential of autologous bone marrow cells in improving cardiac function after myocardial infarction and in chronic heart disease.
  • To explore stem cell therapy for non-ischemic cardiomyopathies and heart failure due to hypertensive heart disease.

Main Methods:

  • Utilizing intracoronary administration of autologous bone marrow cells or precursor cells.
  • Conducting preclinical and clinical trials to assess therapeutic outcomes.
  • Investigating the effectiveness of stem cell therapy across different ages of myocardial infarction.

Main Results:

  • Intracoronary stem cell therapy with autologous bone marrow cells is a safe therapeutic procedure for heart disease.
  • Transplantation of these cells has demonstrated improvement in cardiac function post-myocardial infarction and in chronic coronary heart disease.
  • The age of infarction does not appear to affect the regenerative capacity of stem cells.

Conclusions:

  • Autologous bone marrow stem cell therapy is ethically justified for most patients needing heart muscle regeneration.
  • This therapy shows significant potential for improving cardiac function in various heart conditions, including ischemic and non-ischemic cardiomyopathies.
  • Stem cell therapy represents a promising regenerative approach for patients with heart failure and damaged cardiac muscle.

More Related Videos

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...